Emerging pathways and future targets for the molecular therapy of pancreatic cancer-Reference-Cited by-同舟云学术

Emerging pathways and future targets for the molecular therapy of pancreatic cancer

Published:2011-08-07 Issue:10 Volume:15 Page:1183-1196
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Vaccaro Vanja,Melisi Davide,Bria Emilio,Cuppone Federica,Ciuffreda Ludovica,Pino Maria Simona,Gelibter Alain,Tortora Giampaolo,Cognetti Francesco,Milella Michele

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14728222.2011.607438

Reference122 articles.

1. Cancer Statistics, 2010

2. Clinical Cancer Advances 2009: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology

3. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

4. Stromal Depletion Goes on Trial in Pancreatic Cancer

5. Current status of targeted agents (TA) in advanced pancreatic cancer (APC): Meta-analysis of randomized clinical trials (RCT)

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Tumor to Bone: Growth Factor Receptors as Key Players in Cancer Metastasis;Frontiers in Bioscience-Landmark;2024-05-13

2. Comparative role of tumor marker CA 242 and CA 19.9 in various pancreatic lesions;Indian Journal of Pathology and Oncology;2023-12-15

3. U0126: Not only a MAPK kinase inhibitor;Frontiers in Pharmacology;2022-08-25

4. Preclinical Evaluation of a New Format of 68Ga- and 111In-Labeled Affibody Molecule ZIGF-1R:4551 for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT;Pharmaceutics;2022-07-15

5. The underlying molecular mechanism of intratumoral radiofrequency hyperthermia-enhanced chemotherapy of pancreatic cancer;Journal of Interventional Medicine;2022-05